Immupharma (IMM)

 

Latest News

ImmuPharma schedules FY results

ImmuPharma will announce its preliminary results for the year ended 31 December on 4 May. At 9:55am: (LON:IMM) Im...

Notice of Results

RNS Number: 2726W Immupharma PLC 26 April 2016 RNS: FOR IMMEDIATE RELEASE 26 APRIL 2016 NOTIFICATION OF PRELIMINARY RESULTS Date: 4 May 2016 ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that it will announce its Preliminary results for the y...

Holding(s) in Company

RNS Number: 0465W Immupharma PLC 22 April 2016 RNS: FOR IMMEDIATE RELEASE 22 APRIL 2016 TR1 NOTIFICATION OF MAJOR INTEREST BY AVIVA ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that it has received a TR-1 by Aviva plc and its subsidiaries...

ImmuPharma starts European patient recruitment for Lupuzor trial

ImmuPharma has opened the first European site for its pivotal phase III clinical trial of Lupuzor, its lead programme for ...

All News

DateHeadlineSource
26-04-16ImmuPharma schedules FY results StockMarketWire
26-04-16Notice of ResultsRNS
22-04-16Holding(s) in CompanyRNS
09-03-16ImmuPharma starts European patient recruitment for Lupuzor trial StockMarketWire
09-03-16First European Site Opens - Patient RecruitmentRNS
08-03-16Holding(s) in CompanyRNS
07-03-16Holding(s) in CompanyRNS
01-03-16EIS and VCT Qualifying Status and Issue of EquityRNS
29-02-16Holding(s) in CompanyRNS
24-02-16ImmuPharma raises GBP7.7mStockMarketWire
24-02-16Issue of EquityRNS
22-02-16ImmuPharma fundraising approved StockMarketWire
22-02-16Result of GMRNS
15-02-16Dosing starts for ImmuPharma's Lupuzor trial StockMarketWire
15-02-16US PATIENTS COMMENCE DOSING IN PHASE III STUDYRNS
05-02-16ImmuPharma raises GBP8.3m via placingStockMarketWire
05-02-16Placing and Subscription Raises £8.3 millionRNS
05-02-16ImmuPharma fundraising to finance Lupuzor trial StockMarketWire
05-02-16Proposed Placing and SubscriptionRNS
21-01-16Holding(s) in CompanyRNS
15-12-15ImmuPharma update on Lupuzor StockMarketWire
15-12-15ImmuPharma & Simbec-Orion - Investigators MeetingRNS
08-12-15Should You Buy KAZ Minerals PLC & ImmuPharma PLC On Tuesday?Motley Fool
07-12-15ImmuPharma update on recruiting for Lupuzor trialStockMarketWire
07-12-15Update on the progress of LupuzorRNS
30-11-15Holding(s) in CompanyRNS
04-11-15Lupuzor Phase III Pivotal Trial UpdateRNS
04-11-15ImmuPharma update on Lupuzor trial StockMarketWire
04-11-15Lupuzor Phase III Pivotal Trial UpdateRNS
23-10-15ImmuPharma non-exec steps down StockMarketWire
23-10-15Directorate ChangeRNS
30-09-15Directorate ChangeRNS
30-09-15Interim ResultsRNS
29-07-15ImmuPharma chairman dies StockMarketWire
29-07-15Richard WarrRNS
27-07-15ImmuPharma clinical trials of Lupuzor 'live' StockMarketWire
27-07-15TERM SHEET SIGNED $14 MILLION FUNDING FOR LUPUZORRNS
25-06-15Lupuzor founder awarded 'CNRS Medal of Innovation'StockMarketWire
25-06-15Lupuzor's Founder Dr Slyviane Muller Awarded MedalRNS
29-05-15ImmuPharma resolutions passed at AGMStockMarketWire

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory